Anticholinergics for patients with asthma?

New England Journal of Medicine

Volumn 363, Issue 18, 2010, Pages 1764-1765

  Smith, Lewis J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; NITRIC OXIDE; PLACEBO; SALMETEROL; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; SALBUTAMOL; SCOPOLAMINE DERIVATIVE;

ADD ON THERAPY; ADULT; ANTIINFLAMMATORY ACTIVITY; ASTHMA; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; EDITORIAL; EOSINOPHIL COUNT; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG FUNCTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOM; THERAPY; TREATMENT OUTCOME; TRIPLE BLIND PROCEDURE; ANALOGS AND DERIVATIVES; DRUG COMBINATION; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ALBUTEROL; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; SCOPOLAMINE DERIVATIVES;

EID: 78049431105     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1009429     Document Type: Editorial

References (11)

1. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel report 3: guidelines for the diagnosis and management of asthma. 2007. (http://www.nhlbi.nih.gov/guidelines/asthma/ asthgdln.pdf.)
2. Bousquet J, Ben-Joseph R, Messonnier M, Alemao E, Gould AL. A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clin Ther 2002;24:1-20. (Pubitemid 34117521)
3. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-24. (Pubitemid 24229008)
4. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26.
5. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363:1715-26.
6. Kerstjens HAM, Brand PLP, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992;327:1413-9.
7. Westby M, Benson M, Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev 2004;3:CD003269.
8. Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008;300:1439-50.
9. Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:948-55.
10. Lane S, Molina J, Plusa T. An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respir Med 2006;100:434-50.
11. Masoli M, Weatherall M, Holt S, Beasley R. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax 2005;60:730-4.